###begin article-title 0
RNase L Mediated Protection from Virus Induced Demyelination
###end article-title 0
###begin p 1
Conceived and designed the experiments: DDCI SAS CCB. Performed the experiments: DDCI PK. Analyzed the data: DDCI SAS DRH PK RHS RAA CCB. Contributed reagents/materials/analysis tools: CCB. Wrote the paper: DDCI SAS DRH RHS CCB.
###end p 1
###begin p 2
###xml 126 137 119 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coronavirus</italic>
###xml 521 524 500 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 984 987 956 959 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 564 585 <span type="species:ncbi:11138">mouse hepatitis virus</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 988 992 <span type="species:ncbi:10090">mice</span>
IFN-alpha/beta plays a critical role in limiting viral spread, restricting viral tropism and protecting mice from neurotropic coronavirus infection. However, the IFN-alpha/beta dependent mechanisms underlying innate anti-viral functions within the CNS are poorly understood. The role of RNase L in viral encephalomyelitis was explored based on its functions in inhibiting translation, inducing apoptosis, and propagating the IFN-alpha/beta pathway through RNA degradation intermediates. Infection of RNase L deficient (RL-/-) mice with a sub-lethal, demyelinating mouse hepatitis virus variant revealed that the majority of mice succumbed to infection by day 12 p.i. However, RNase L deficiency did not affect overall control of infectious virus, or diminish IFN-alpha/beta expression in the CNS. Furthermore, increased morbidity and mortality could not be attributed to altered proinflammatory signals or composition of cells infiltrating the CNS. The unique phenotype of infected RL-/- mice was rather manifested in earlier onset and increased severity of demyelination and axonal damage in brain stem and spinal cord without evidence for enhanced neuronal infection. Increased tissue damage coincided with sustained brain stem infection, foci of microglia infection in grey matter, and increased apoptotic cells. These data demonstrate a novel protective role for RNase L in viral induced CNS encephalomyelitis, which is not reflected in overall viral control or propagation of IFN-alpha/beta mediated signals. Protective function is rather associated with cell type specific and regional restriction of viral replication in grey matter and ameliorated neurodegeneration and demyelination.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 747 758 740 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coronavirus</italic>
###xml 688 692 <span type="species:ncbi:10090">mice</span>
Initial spread of viruses is controlled by type I interferon induced antiviral molecules. Early intervention with viral replication is especially critical in central nervous system infections to reduce loss of non-renewable cells and mitigate immune pathology. One of the best characterized anti-viral mechanisms is mediated by ribonuclease L (RNase L). RNase L exerts activity at multiple levels, including degradation of viral and host RNA, induction of apoptosis, and propagation of the IFN-alpha/beta pathway. Recent studies suggest that RNase L antiviral activity is dependent on the virus, as well as the cell type and tissue infected. This study demonstrates that RNase L protects mice infected with a sub-lethal, demyelinating neurotropic coronavirus by ameliorating encephalitis and morbidity, albeit without affecting control of infectious virus or IFN-alpha/beta expression. RNase L specifically protected the brain stem from sustained infection and prevented spread of virus to microglia/macrophages located in spinal cord grey matter. The subtle regional alteration in tropism in the absence of RNase L coincided with increased apoptotic cells and earlier onset as well as increased severity of axonal damage and demyelination. The results demonstrate how subtle regional alterations in viral tropism within the CNS may severely affect the balance between neuroprotection and neurotoxicity mediated by microglia/macrophages.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 542 545 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Borden1">[1]</xref>
###xml 621 624 614 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-GarciaSastre1">[2]</xref>
Type I interferon (IFN-alpha/beta) induced anti-viral responses are critical for the initial control of most virus infections. Although anti-viral responses are initiated in infected cells, they act in an autocrine and paracrine fashion, antagonizing virus replication in host cells and inducing a protective anti-viral state in neighboring cells. The anti-viral state is distinguished by the expression of numerous IFN stimulated genes (ISG), which directly or indirectly interfere with both viral and host RNA transcription and translation [1]. Many of these pathways can also result in the apoptosis of infected cells [2]. Nevertheless, the relative contributions of these various anti-viral effector mechanisms to overall virus control differ with the virus as well as the tissue and cell type infected.
###end p 6
###begin p 7
###xml 203 206 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Silverman1">[3]</xref>
###xml 207 210 207 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Garcia1">[5]</xref>
###xml 976 979 962 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bisbal1">[6]</xref>
###xml 1148 1151 1134 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Malathi1">[7]</xref>
The best characterized anti-viral mechanisms are mediated by activation of double-stranded RNA-dependent protein kinase (PKR) and the 2'-5'-oligoadenylatesynthase (OAS)/ribonuclease L (RNase L) pathways [3]-[5]. Upon recognition of double-stranded RNA, the OAS family of proteins convert ATP into unique, unstable 2'-5'-A oligomers, which are bound by latent RNase L monomers, driving the dimerization and activation of RNase L. Activated RNase L cleaves single-stranded RNA, 3' of U-A and U-U sites found in both viral and cellular RNA. RNase L endoribonuclease activity is thus not limited to viral RNA, but also degrades host cell RNA, including ribosomal RNA. As OAS genes are stimulated by IFN-alpha/beta, elevated OAS levels enhance the anti-viral state in adjacent, non-infected cells responding to IFN-alpha/beta. Nevertheless, inappropriate activation of RNase L is counterbalanced by the unstable nature of 2'-5'A oligomers and the endogenous RNase L inhibitor, RL1 [6]. A novel aspect of the OAS/RNase L pathway is the cleavage of host RNA releasing free 3'-monophosphates that can activate the cytoplasmic RNA helicases RIG-I and Mda-5 [7]. Recognition by these pattern recognition receptors initiates IFN-beta transcription, similar to the activation mediated by recognition of specific viral RNA structures. RNase L thus not only exerts anti-viral effects via RNA degradation and apoptosis, but also has the capacity to amplify and prolong expression of anti-viral genes and other ISGs.
###end p 7
###begin p 8
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 108 115 108 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 115 118 115 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Silverman1">[3]</xref>
###xml 119 122 119 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Silverman2">[4]</xref>
###xml 590 593 590 593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 677 684 677 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 753 756 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 900 903 897 900 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1002 1005 999 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Zhou1">[8]</xref>
###xml 1081 1093 1078 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">picornavirus</italic>
###xml 1183 1186 1180 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1365 1372 1362 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1425 1428 1422 1425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1471 1479 1464 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1605 1608 1594 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-FlodstromTullberg1">[9]</xref>
###xml 1696 1704 1685 1693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1709 1716 1698 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1922 1926 1911 1915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Scherbik1">[10]</xref>
###xml 2052 2056 2038 2042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 2184 2185 2170 2171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2213 2216 2199 2202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2237 2241 2223 2227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 2281 2284 2267 2270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2622 2625 2608 2611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2742 2745 2728 2731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2823 2827 2809 2813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 3002 3009 2988 2995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 492 518 <span type="species:ncbi:12104">encephalomyocarditis virus</span>
###xml 520 524 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 904 908 <span type="species:ncbi:10090">mice</span>
###xml 1095 1112 <span type="species:ncbi:12073">Coxsackievirus B4</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:10090">mice</span>
###xml 1819 1834 <span type="species:ncbi:11082">West Nile virus</span>
###xml 1836 1839 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1848 1853 <span type="species:ncbi:10090">mouse</span>
###xml 1989 1992 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 2232 2236 <span type="species:ncbi:10090">mice</span>
###xml 2285 2289 <span type="species:ncbi:10090">mice</span>
###xml 2316 2319 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 2478 2481 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 2633 2637 <span type="species:ncbi:10090">mice</span>
###xml 2746 2750 <span type="species:ncbi:10090">mice</span>
###xml 2875 2878 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
The anti-viral activity of the OAS/RNase L system has been studied in several virus infections in vitro and in vivo[3],[4]. Protective mechanisms of the OAS/RNase L pathway are generally more evident for RNA relative to DNA virus infections. However, the contribution of RNase L to disease severity and viral control varies significantly depending on the virus and even virus strain studied, presumably reflecting the diverse mediators and targets of these anti-viral mediators. For example, encephalomyocarditis virus (EMCV) replication was only modestly increased in RNase L deficient (RL-/-) mouse embryonic fibroblasts, consistent with enhanced susceptibility to infection in vivo. Although RNase L prolonged survival, mortality rates of infected RL-/- and control mice were similar. Furthermore, IFN-beta treatment increased the survival time of infected wild-type (wt) and to a lesser extent RL-/- mice, indicating that alternate IFN-dependent anti-viral mechanisms act in the absence of RNase L [8]. In contrast, the requirement for RNase L activity to protect from another picornavirus, Coxsackievirus B4, was evident by significantly increased mortality rates of infected RL-/- compared to wt mice. However, increased mortality was not the result of uncontrolled virus replication, as virus titers were only slightly elevated within pancreatic islet cells in vivo. By contrast, pancreatic islet cells derived from RL-/- mice, treated with IFN-alpha and infected in vitro exhibited increased virus replication and loss of cellular integrity, compared to IFN-alpha treated RNase L sufficient cells [9]. These results revealed distinct differences in direct anti-viral functions of RNase L in vitro and in vivo. Cell type specific effects of anti-viral RNase L activity are also clearly evident from studies with West Nile virus (WNV). While mouse embryonic fibroblasts display RNase L dependent anti-viral activity [10], IFN-beta treatment revealed no affect of RNase L in reducing WNV replication in either cortical or peripheral motor neurons [11]. Nevertheless, a modest effect was observed in bone marrow derived macrophages, consistent with increased viral burden in CD11b+ splenocytes derived from RL-/- compared to wt mice [11]. Furthermore, increased mortality of RL-/- mice in response to peripheral WNV infection correlated with increased replication in lymphoid tissue, but not enhanced viral dissemination into the CNS. A minor role for RNase L in control of WNV in the CNS was supported by similar viral titers in brains as well as kinetics and rates of mortality following intracranial infection of RL-/- and wt mice. Although viral replication was only transiently increased in spinal cords of intracranially infected RL-/- mice, the most prominent effect was increased spread to the spleen and liver [11]. The more critical role of RNase L in limiting WNV spread in peripheral tissues rather than the CNS highlights the complexities of OAS/RNase L mediated anti-viral mechanisms in vivo.
###end p 8
###begin p 9
###xml 112 123 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">coronavirus</italic>
###xml 135 139 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 140 144 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-CervantesBarragan2">[15]</xref>
###xml 157 165 150 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 170 177 163 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 264 268 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 269 273 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Rempel1">[16]</xref>
###xml 274 278 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-RothCross1">[17]</xref>
###xml 394 402 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 567 571 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ye1">[18]</xref>
###xml 700 708 686 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 722 729 708 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 729 733 715 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Fingerote1">[19]</xref>
###xml 796 803 782 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1052 1056 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bergmann1">[20]</xref>
###xml 1057 1061 1043 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Lane1">[21]</xref>
###xml 1182 1186 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Lane1">[21]</xref>
###xml 1334 1337 1313 1316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1339 1343 1318 1322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 1487 1490 1466 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1552 1555 1531 1534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1778 1781 1757 1760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 435 438 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 661 664 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 897 918 <span type="species:ncbi:11138">mouse hepatitis virus</span>
###xml 920 923 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 1284 1288 <span type="species:ncbi:10090">mice</span>
###xml 1360 1363 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 1470 1474 <span type="species:ncbi:10090">mice</span>
###xml 1491 1495 <span type="species:ncbi:10090">mice</span>
###xml 1556 1560 <span type="species:ncbi:10090">mice</span>
###xml 1782 1786 <span type="species:ncbi:10090">mice</span>
###xml 1918 1922 <span type="species:ncbi:10090">mice</span>
IFN-alpha/beta mediated innate responses are also essential to control virus replication and survival following coronavirus infections [12]-[15]. Infections in vitro and in vivo induce upregulation of IFN-alpha/beta and anti-viral mediators, including PKR and OAS [12],[16],[17]; however, the participation of these pathways in the anti-viral response to CNS infection has not been elucidated. In vitro, the dual liver and neurotropic MHV-A59 strain does not elicit degradation of 18S and 28S ribosomal RNA, suggesting the absence of RNase L activation in HELA cells [18]. However, administration of an RNase L agonist inhibited replication of the hepatotropic MHV-3 strain in peritoneal macrophages in vitro and in liver in vivo[19]. Nevertheless, reduced viral replication via RNase L function in vivo was insufficient to prevent liver necrosis and death. The nonlethal gliotropic JHM strain of mouse hepatitis virus (MHV-JHM) replicates exclusively in the CNS following intracranial infection and is controlled by both innate and adaptive responses [20],[21]. CNS infection results in a non-lethal encephalitis with immune-mediated demyelination resulting in hind limb paralysis [21]. Based on expanded tropism to hippocampal neurons and widespread dissemination within the CNS of mice deficient in IFN-alpha/beta signalling (IFNAR-/-) [12], the gliotropic MHV-JHM variant was used to probe an anti-viral role of RNase L within the CNS. While the vast majority of wt mice survived, RL-/- mice succumbed to infection, albeit delayed compared to IFNAR-/- mice. Although enhanced morbidity suggested a prominent role of RNase L in anti-viral protection, the absence of RNase L neither diminished overall virus control in the CNS, nor enhanced neuronal infection. Furthermore, RL-/- mice did not reveal any impairment in IFN-alpha/beta induction, alterations in proinflammatory cytokines or inflammation compared to wt mice. These data rather reveal a novel role of RNase L in specifically counteracting focal microglia/macrophage infection, thus potentially sustaining microglia mediated neuroprotective effects and ameliorating demyelination.
###end p 9
###begin title 10
Results
###end title 10
###begin title 11
RNase L deficiency increases morbidity without affecting virus control
###end title 11
###begin p 12
###xml 165 169 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 435 438 421 424 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 444 447 430 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Zhou1">[8]</xref>
###xml 479 482 465 468 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 591 597 577 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g001">Fig. 1</xref>
###xml 710 713 696 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 989 992 975 978 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1054 1060 1040 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g001">Fig. 1</xref>
###xml 1125 1128 1111 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1134 1138 1120 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 1193 1196 1179 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-FlodstromTullberg1">[9]</xref>
###xml 1197 1201 1183 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 1269 1272 1255 1258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1340 1342 1326 1328 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sub>
###xml 1348 1351 1334 1337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1358 1364 1344 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g001">Fig. 1</xref>
###xml 1604 1607 1590 1593 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1647 1654 1633 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000602-t001">Table 1</xref>
###xml 1976 1983 1962 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000602-t001">Table 1</xref>
###xml 2033 2036 2019 2022 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2251 2258 2237 2244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2303 2315 2289 2301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">picornavirus</italic>
###xml 2323 2326 2309 2312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Zhou1">[8]</xref>
###xml 2327 2330 2313 2316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-FlodstromTullberg1">[9]</xref>
###xml 2331 2335 2317 2321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 90 93 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 399 402 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 483 487 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
###xml 993 997 <span type="species:ncbi:10090">mice</span>
###xml 1129 1133 <span type="species:ncbi:10090">mice</span>
###xml 1289 1293 <span type="species:ncbi:10090">mice</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1623 1627 <span type="species:ncbi:10090">mice</span>
###xml 1732 1736 <span type="species:ncbi:10090">mice</span>
###xml 2037 2041 <span type="species:ncbi:10090">mice</span>
###xml 2176 2181 <span type="species:ncbi:10090">mouse</span>
Mice deficient in IFN-alpha/beta signalling succumb to an otherwise sub-lethal gliotropic MHV-JHM within 8 days of infection despite functional CD8 T cell responses [12]. Uncontrolled viral replication in the absence of IFN-alpha/beta implicated a crucial role of anti-viral innate mechanisms in stemming viral spread within the CNS. To elucidate the role of RNase L in CNS pathogenesis, gliotropic MHV-JHM infection was examined in RL-/- mice [8]. Increased susceptibility of RL-/- mice was evident by more severe clinical symptoms of acute encephalitis at 9-11 days post infection (p.i.) (Fig. 1, top panel). With the exception of increased severity, onset and progression of clinical symptoms in infected RL-/- were similar to those exhibited by infected wt mice. These included initial symptoms of acute viral encephalitis, including: lethargy, dehydration and weight loss, which progressed to diminished hind limb function. Furthermore, mortality rates were significantly higher in RL-/- mice, with over 90% succumbing to infection by 12 days p.i. (Fig. 1, middle panel), approximately 3-4 days delayed relative to IFNAR-/- mice [12]. Assessment of direct anti-viral functions of RNase L [9],[11] revealed no significant changes of infectious virus in brains of RL-/-, compared to wt mice. Virus titers were increased less than 0.5 log10 in RL-/- mice (Fig. 1, bottom panel). Very modest anti-viral RNase L activity in the CNS was confirmed by analysis of viral RNA from CNS tissue. Levels of viral mRNA encoding the viral nucleocapsid protein were increased less than 2.4-fold in spinal cords of RL-/- compared to wt mice at any time point (Table 1). As liver may constitute an extraneural infection site in immunocompromised mice, viral replication in this tissue was also assessed by real-time PCR. The abundant viral mRNA encoding the nucleocapsid protein was detected in liver at very low levels compared to the CNS in both groups, albeit only at early time points (Table 1). Although viral RNA was elevated in livers of RL-/- mice at day 7 p.i., clearance by day 10 p.i. suggested hepatitis did not contribute to mortality. Necrotic foci were not evident in either mouse group by gross examination. A minor role of RNase L in viral control in vivo was reminiscent of the previously described picornavirus models [8],[9],[11].
###end p 12
###begin title 13
###xml 72 75 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
RNase L ameliorates clinical symptoms and is required for recovery from MHV-JHM.
###end title 13
###begin p 14
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 170 173 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 67 70 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 219 222 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
Top Panel: Morbidity of wt and RL-/- mice infected with gliotropic MHV-JHM. Data are the average of two independent experiments. Middle Panel: Survival rates of wt and RL-/- (n = 16/group) following i.c. infection with MHV-JHM. Data are representative of two independent experiments. Bottom Panel: Virus replication in the brains of infected mice is not significantly altered by RNase L deficiency (n = 6/group).
###end p 14
###begin title 15
Levels of viral nucleocapsid protein encoding mRNA in CNS and liver.
###end title 15
###begin p 16
relative to GAPDH.
###end p 16
###begin p 17
###xml 21 25 <span type="species:ncbi:10090">mice</span>
SD from 3 individual mice.
###end p 17
###begin p 18
below detection.
###end p 18
###begin title 19
RNase L deficiency does not impair type I IFN responses in the CNS
###end title 19
###begin p 20
###xml 150 153 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Malathi1">[7]</xref>
###xml 449 452 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 479 485 465 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g002">Fig. 2</xref>
###xml 655 658 641 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 767 770 746 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 128 140 <span type="species:ncbi:11191">Sendai virus</span>
###xml 145 149 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 430 433 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 1103 1106 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
In addition to RNA degradation, RNase L also induces a multitude of genes in the IFN-alpha/beta pathways during infections with Sendai virus and EMCV [7]. Thus, both self and virus small RNA products released by RNase L activate cytoplasmic RNA helicases RIG-I and Mda-5 to optimize and perpetuate anti-viral responses. However, IFN-alpha and IFN-beta expression levels were slightly increased, rather than decreased in brains of MHV-JHM infected RL-/- mice relative to wt mice (Fig. 2). Furthermore, OAS-2, IFIT-1, IFIT-2, and IRF-7, representing prominently activated ISGs, were induced to similar, or modestly increased levels in the CNS of infected RL-/- mice. Slightly enhanced IFN-alpha/beta and ISG expression was also observed in spinal cords from infected RL-/- relative to wt mice (data not shown). Consistent with similar virus replication and control in the CNS, neither IFN-alpha/beta nor the expression of downstream ISGs were impaired at the tissue level. These data suggest that a positive RNase L-dependent feedback loop in propagating IFN-alpha/beta signalling is not activated during MHV-JHM infection in the CNS.
###end p 20
###begin title 21
###xml 40 43 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
RNase L does not alter IFN responses to MHV-JHM infection of the CNS.
###end title 21
###begin p 22
###xml 152 155 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 126 129 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 197 202 <span type="species:ncbi:10090">mouse</span>
Expression of IFN-alpha4, IFN-beta1, OAS2, IFIT-1, IFIT-2 and IRF-7 mRNA relative to the housekeeping gene GAPDH in brains of MHV-JHM infected wt and RL-/- mice. Data are the average of individual mouse brains from two independent experiments (n = 6).
###end p 22
###begin title 23
RNase L does not alter CNS inflammatory responses
###end title 23
###begin p 24
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Silverman3">[22]</xref>
###xml 530 536 530 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g003">Fig. 3</xref>
###xml 551 554 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 612 615 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 708 709 708 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 717 718 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 825 826 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 952 953 952 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 985 989 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bergmann2">[23]</xref>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
An unanticipated feature of RL-/- mice is delayed tissue rejection in transplant studies [22], suggesting a role of RNase L in modifying antigen presentation, lymphocyte trafficking or function. To assure that altered pathogenesis was not due to differential inflammatory responses, the CNS was examined for extent, composition and localization of infiltrating cells. Characterization of cells recruited to the CNS using flow cytometry revealed similar total numbers of infiltrating cells and no alterations in their composition (Fig. 3). Unlike IFNAR-/- mice [12], neutrophil infiltration was not affected in RL-/- mice and macrophages comprised the most prominent population early p.i. in both strains. CD4+ and CD8+ T cells peaked to nearly identical numbers at day 7 p.i. in both groups. Furthermore, CNS infiltrating CD8+ T cells in both groups were comprised of 50% and 60% virus specific cells at day 7 and 10 pi, respectively, as monitored by Db/S510 class I tetramer staining [23]. Similarly, no significant differences in the extent of inflammatory cells were observed by histochemical analysis (data not shown). These data confirm that priming and trafficking of virus specific T cells was unaffected by the loss of RNase L activity, consistent with effective clearance of infectious virus.
###end p 24
###begin title 25
RNase L does not alter CNS inflammation.
###end title 25
###begin p 26
###xml 31 33 31 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 193 195 193 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 358 359 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 487 488 487 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Numbers and composition of CD45hi inflammatory cells derived from brains of infected wt and RL-/- mice analyzed by flow cytometry at the indicated times p.i. Numbers of bone marrow derived CD45hi cells/brain are shown in the top left panel. Composition of cell infiltrates is indicated by relative percentages of Ly-6G+ neutrophils (ND = not detected), F4/80+ macrophages, CD4 T cells, and CD8 T cells. Percentages of virus-specific CD8 T cells within the CD8 population is assessed by Db/S510 tetramer staining (CD8+Tet+). Data are the mean of two independent experiments+/-SEM.
###end p 26
###begin title 27
###xml 47 50 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
RNase L protects the brain stem from sustained MHV-JHM infection and apoptosis
###end title 27
###begin p 28
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Wang1">[24]</xref>
###xml 448 452 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 805 808 798 801 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 822 828 815 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g004">Fig. 4</xref>
###xml 1088 1091 1081 1084 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1230 1233 1223 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1288 1294 1281 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g004">Fig. 4</xref>
###xml 1419 1422 1412 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1667 1670 1660 1663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1676 1680 1669 1673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 1820 1823 1813 1816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 132 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 298 301 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 816 820 <span type="species:ncbi:10090">mice</span>
###xml 1013 1021 <span type="species:ncbi:55096|species:ncbi:59563|species:ncbi:290008|species:ncbi:45269|species:ncbi:490111|species:ncbi:467989|species:ncbi:426790|species:ncbi:348026|species:ncbi:64308|species:ncbi:273356|species:ncbi:249583|species:ncbi:225976|species:ncbi:159145|species:ncbi:273341">i. virus</span>
###xml 1092 1096 <span type="species:ncbi:10090">mice</span>
###xml 1125 1129 <span type="species:ncbi:10090">mice</span>
###xml 1234 1238 <span type="species:ncbi:10090">mice</span>
###xml 1430 1434 <span type="species:ncbi:10090">mice</span>
###xml 1671 1675 <span type="species:ncbi:10090">mice</span>
###xml 1824 1828 <span type="species:ncbi:10090">mice</span>
RNase L did not overtly affect overall CNS viral replication; however, it may act in a tissue or cell type specific manner [11]. MHV-JHM initially infects ependymal cells and spreads to astrocytes, microglia/macrophages and predominantly oligodendrocytes, but rarely infects neurons [24]. However, MHV-JHM induced mortality in the absence of IFN-alpha/beta signalling is associated with a dramatically expanded virus tropism to hippocampal neurons [12]. To assess the possibility that RNase L exerts cell type dependent anti-viral effects not apparent from whole tissue homogenates, the distribution of virus infected cells was analysed by immunohistochemistry. Sequential analysis demonstrated a limited infection of neurons within the brain with a predominance in the brain stem at day 5 p.i. in both RL-/- and wt mice (Fig. 4). Glia tropism prevailed in both groups and overall distribution of virus infected cells was similar with occasional neurons still infected at day 7 p.i. (data not shown). By day 10 p.i. virus infected cells declined in cortex and brain stem of both wt and RL-/- mice. However, in contrast to wt mice which had cleared virus from brain stem, virus infected cells were sustained in the brain stem of RL-/- mice and were predominantly microglial in appearance (Fig. 4). The overall extent and distribution of viral infected cells was thus similar during peak virus replication in brains of RL-/- and wt mice, with the exception of sustained infection in brain stem in the absence of RNase L. Preliminary experiments indicate that these cells are microglia or macrophage/monocytes (see below). These data contrast with the infection of IFNAR-/- mice [12] which show predominant neuronal infection. Therefore, preferential infection of neurons could not account for the increased mortality in RL-/- mice. The data also indicated that protective RNase L functions are not overtly reflected in early anti-viral activity but are manifested in region specific protection.
###end p 28
###begin title 29
RNase L does not alter the extent of neuronal infection but delays viral clearance from brain stem.
###end title 29
###begin p 30
###xml 114 117 114 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 443 446 443 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 638 641 634 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
Viral nucleocapsid antigen detected by immunoperoxidase staining using mAb J.3.3 in brains from infected wt and RL-/- mice at days 5 and 10 p.i. (top panels: brown chromogen; hematoxylin counterstain). Note neuronal infection (arrows) and similar foci of viral antigen in glial cells in brain stem at day 5 p.i. By day 10 p.i. infection is controlled in wt mice, but foci of infected non neuronal cells with glia morphology are sustained in RL-/- mice. Scale bar = 100 microm. Immunohistochemical staining for activated caspase-3 (bottom panels) at day 10 p.i. indicates increased numbers of cells undergoing apoptosis in brain stem of RL-/- relative to wt mice. Scale bar = 100 microm.
###end p 30
###begin p 31
###xml 113 116 113 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Silverman1">[3]</xref>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bisbal2">[25]</xref>
###xml 226 229 219 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Zhou1">[8]</xref>
###xml 315 319 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Stohlman1">[26]</xref>
###xml 528 532 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Gonzalez1">[27]</xref>
###xml 533 537 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Schwartz1">[28]</xref>
###xml 898 901 891 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 908 914 901 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g004">Fig. 4</xref>
###xml 238 241 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 493 496 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
###xml 902 906 <span type="species:ncbi:10090">mice</span>
RNase L activation leads to apoptosis and elimination of infected cells, a process requiring activated caspase 3 [3],[25]. Furthermore, IFNalpha/beta mediated activation of RNase L also induces apoptosis in non-infected cells [8]. During MHV-JHM infection of wt mice the majority of apoptotic cells are lymphocytes [26], which are not targets of infection. Although oligodendrocyte apoptosis has been linked to the demyelinating process, the demonstration of apoptotic oligodendrocytes during MHV-JHM infection has been elusive [27],[28]. The retention of virus infected cells in brain stem may result in enhanced local T cell activation and apoptosis of either T cells, infected cells, or both. Therefore, the frequency of apoptotic cells was examined at day 10 p.i. In contrast to the brain stems of wt mice which contained few apoptotic cells, apoptotic cells were prominent in brain stems of RL-/- mice (Fig. 4) coincident with retention of virus infected cells. Although increased focal virus infection associated with substantially increased apoptotic cells presumably dysregulates neuronal function and potentiates tissue damage, there was no evidence that apoptotic cells are preferentially located adjacent to neurons.
###end p 31
###begin title 32
RNase L ameliorates demyelination and axonal damage
###end title 32
###begin p 33
###xml 50 53 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 450 456 450 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g005">Fig. 5</xref>
###xml 522 525 522 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Tsunoda1">[29]</xref>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Howe1">[30]</xref>
###xml 815 819 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Templeton1">[31]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Dandekar1">[32]</xref>
###xml 960 963 960 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1074 1080 1074 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g005">Fig. 5</xref>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 180 183 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 756 759 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 879 883 <span type="species:ncbi:10090">mice</span>
###xml 964 968 <span type="species:ncbi:10090">mice</span>
Sustained brain stem infection and apoptosis in RL-/- mice coincided with increased morbidity and mortality, despite similar overall control of viral replication. The morbidity in MHV-JHM infected RL-/- mice also coincided temporally with the onset of acute primary demyelination in wt mice. RL-/- mice were thus examined for enhanced tissue pathology and demyelination. Brain stems of infected wt mice revealed minimal demyelination by day 10 p.i. (Fig. 5). By contrast, demyelination was more severe in brain stems of RL-/- mice, correlating with increased numbers of virus infected as well as apoptotic cells. Demyelination is associated with a variable degree of axonal damage [29],[30]. Primary immune mediated demyelination in the spinal cord during MHV-JHM infection coincides with early axonal degeneration [31],[32]. While axons were largely intact in brain stems of wt mice, axonal integrity within demyelinated lesions was severely compromised in RL-/- mice as indicated by a striking decrease in neurofilament and an increase in dystrophic axons within lesions (Fig. 5).
###end p 33
###begin title 34
Increased demyelination and axonal damage in brain stem.
###end title 34
###begin p 35
###xml 33 36 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 315 318 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
Brain stems of infected wt and RL-/- mice at day 10 p.i. stained with Luxol Fast Blue (top panels). Scale bar = 100 microm. Immunohistochemical staining for axonal integrity in brain stem at day 10 p.i. (bottom panels) Scale bar = 100 microm. Note more abundant loss of myelin and axonal degeneration in infected RL-/- relative to wt mice.
###end p 35
###begin p 36
###xml 103 109 103 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g006">Fig. 6</xref>
###xml 166 173 166 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000602-t001">Table 1</xref>
###xml 258 261 258 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 686 689 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 789 792 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 661 665 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
###xml 793 797 <span type="species:ncbi:10090">mice</span>
In spinal cords of wt mice, demyelination was also minimal at day 7 p.i. and increased by day 10 p.i. (Fig. 6), when control of virus replication is clearly evident (Table 1). By contrast, large focal areas of severe demyelination were already apparent in RL-/- mice at day 7 p.i., resembling those in wt mice at day 10 p.i. In addition to the accelerated kinetics of demyelination, the severity of myelin loss was more pronounced in the absence of RNase L at both days 7 and 10 p.i. Consistent with the more rapid loss of myelin in infected RL-/- mice, quantification of demyelinated areas at day 7 p.i. revealed 1.2+/-0.8% demyelination in spinal cords of wt mice and 3.0+/-1.7% in RL-/- mice. Increased demyelination in both brain stem and spinal cord are thus a hallmark of infected RL-/- mice, irrespective of overall viral control.
###end p 36
###begin title 37
RNase L mitigates spinal cord demyelination.
###end title 37
###begin p 38
###xml 34 37 34 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Spinal cords of infected wt and RL-/- mice at day 7 (top) and day 10 (bottom) p.i. stained with Luxol Fast Blue. Scale bar = 100 microm.
###end p 38
###begin p 39
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 297 303 297 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g007">Fig. 7</xref>
###xml 339 342 339 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 573 576 573 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 697 703 697 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g007">Fig. 7</xref>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
Apoptotic cell numbers and axonal damage in the spinal cords of RL-/- mice were also evaluated to determine an association with increased demyelination. In wt mice, apoptotic cells were undetectable in spinal cord at day 7 p.i. (data not shown), but were prominent in white matter by day 10 p.i. (Fig. 7). By contrast, spinal cords from RL-/- mice already exhibited small areas of apoptotic cells at 7 days p.i., albeit only in white matter. However, by day 10 p.i. numerous apoptotic cells were evident in both white matter and grey matter of spinal cords from infected RL-/- mice. Furthermore, in contrast to brain stems, apoptotic cells were often detected in close proximity to neurons (inset Fig. 7); however, there was no evidence for neuronal apoptosis. These data suggest that the absence, rather than presence, of RNase L contributes to enhanced apoptosis in white matter, and subsequently also in grey matter.
###end p 39
###begin title 40
RNase L regulates apoptosis and ameliorates axonal degeneration.
###end title 40
###begin p 41
###xml 152 155 152 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 520 523 512 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
Immunohistochemical staining for activated caspase-3 (top panels) at day 10 p.i. indicates apoptosis in grey matter (above line) of spinal cords from RL-/- mice, but not wt mice. Scale bar = 50 microm. Inset shows a large neuron (arrow) surrounded by five apoptotic cells. Scale bar = 20 microm. Immunohistochemical staining for axonal integrity at day 7 (middle panels) and day 10 (bottom panels) p.i. in spinal cord white matter. Note earlier and more abundant loss of axonal integrity in spinal cords from infected RL-/- relative to wt mice. Scale bar = 100 microm.
###end p 41
###begin p 42
###xml 145 151 145 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g007">Fig. 7</xref>
###xml 343 346 343 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 446 449 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 559 562 559 562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 627 633 627 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g007">Fig. 7</xref>
###xml 791 794 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 795 799 <span type="species:ncbi:10090">mice</span>
Analysis of axonal integrity revealed that all axons were intact in spinal cords of wt mice consistent with minimal demyelination at day 7 p.i. (Fig. 7). By contrast, a striking decrease in neurofilament and an increase in dystrophic axons within demyelinated lesions demonstrated axonal integrity was already compromised in white matter of RL-/- mice by day 7 p.i. At day 10 p.i. the amount of axonal degeneration in wt mice resembled that of RL-/- mice at day 7 p.i., consistent with the severity of demyelination. However, by day 10 p.i. spinal cords of RL-/- mice showed marked axonal loss located in areas of myelin loss (Fig. 7), similar to results in brain stem. The increased pathological changes in both brain stem and spinal cord thus correlated with the high mortality rates of RL-/- mice starting at day 9 p.i.
###end p 42
###begin title 43
RNase L prevents viral spread to grey matter microglia/macrophages in spinal cords
###end title 43
###begin p 44
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-DasSarma1">[33]</xref>
###xml 531 534 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 923 926 923 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1038 1041 1038 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1085 1091 1085 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g008">Fig. 8</xref>
###xml 1198 1201 1198 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1372 1378 1372 1378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g008">Fig. 8</xref>
###xml 1451 1454 1451 1454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1571 1577 1571 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g009">Fig. 9</xref>
###xml 1680 1683 1680 1683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1754 1760 1754 1760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g008">Fig. 8</xref>
###xml 1862 1865 1862 1865 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2232 2235 2232 2235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 435 438 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
###xml 933 937 <span type="species:ncbi:10090">mice</span>
###xml 1042 1046 <span type="species:ncbi:10090">mice</span>
###xml 1065 1069 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
###xml 1366 1370 <span type="species:ncbi:10090">mice</span>
###xml 1455 1459 <span type="species:ncbi:10090">mice</span>
###xml 1695 1699 <span type="species:ncbi:10090">mice</span>
###xml 1866 1870 <span type="species:ncbi:10090">mice</span>
###xml 2236 2240 <span type="species:ncbi:10090">mice</span>
The inability to directly link increased axonal damage with enhanced neuronal infection remains puzzling and supports dysregulation of oligodendrocyte function and/or neuroprotective functions of microglia as contributing factors to the severe pathological phenotype and clinical outcome. Increased demyelination in spinal cords has been correlated with the extent of white and grey matter infection in mice infected with heterologous MHV strains [33]. Furthermore increased apoptosis, specifically in spinal cord grey matter of RL-/- mice supported grey matter infection. Increased demyelination as well as apoptosis in grey matter in RL-/- mice thus prompted a more detailed investigation of viral antigen distribution in spinal cords, where the demarcation between grey and white matter is linear as opposed to the more complex organization of brain stem. Neuronal infection was not observed in spinal cords of either RL-/- or wt mice. Furthermore, the number of infected cells with oligodendrocyte morphology in the white matter of RL-/- mice was similar to wt mice at day 7 p.i. (Fig. 8). However, a prominent difference in viral antigen positive cells was noted in spinal cord grey matter. RL-/- mice harboured several foci of infected cells with microglia morphology, whereas viral antigen positive cells were rarely observed in spinal cord grey matter of wt mice (Fig. 8). Furthermore, a large number of infected cells in the grey matter of RL-/- mice were identified as microglia and/or infiltrating monocytes based on co-localization with Iba-1 positive cells (Fig. 9). Foci of Iba-1 positive cells co-expressing viral antigen in the grey matter were only observed in RL-/- but not wt mice, confirming results obtained by immunohistochemistry (Fig. 8). Nevertheless, infected Iba-1 positive cells were dispersed throughout the white matter of wt and RL-/- mice. Similar characterization of the brain stem at day 10 p.i. also identified Iba -1 positive cells as prominent cells harbouring sustained viral infection (data not shown). Co-stains with the astrocyte specific marker GFAP showed no evidence of infected astrocytes in spinal cord grey matter; astrocytes were also only rarely infected in white matter of wt and RL-/- mice (data not shown). These data indicate that RNase L mediated antiviral function acts specifically in microglia and/or monocytes. Moreover the focal nature of infection in grey matter suggests microglia localization is associated with enhanced susceptibility to infection in the absence of RNase L.
###end p 44
###begin title 45
###xml 27 30 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
RNase L prevents spread of MHV-JHM to spinal cord grey matter.
###end title 45
###begin p 46
###xml 53 56 53 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 241 245 <span type="species:ncbi:10090">mice</span>
Viral antigen in spinal cords from infected wt and RL-/- mice at day 7 p.i. Note spread of virus into the grey matter (GM) (arrows, bottom panel) is only observed in RL-/- mice, whereas viral antigen is restricted to white matter (WM) in wt mice. Also note the absence of infected neurons. Scale bar = 50 microm.
###end p 46
###begin title 47
RNase L protects microglia/macrophages from infection in grey matter.
###end title 47
###begin p 48
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 428 431 428 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
Virus infected cells detected using virus nucleocapsid protein specific mAb J.3.3 (Antigen - green) and macrophage/microglia cell marker Iba-1 (Iba-1 - red) in spinal cords from infected wt and RL-/- mice at day 7 p.i. Co-localization of viral antigen and Iba-1 staining cells (Merge - yellow) indicates infected microglia/macrophages are present only in white matter (WM) of wt, but both white matter and grey matter (GM) in RL-/- spinal cords. Scale bar = 100 microm.
###end p 48
###begin p 49
###xml 316 319 316 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 482 489 482 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000602-t002">Table 2</xref>
###xml 915 918 907 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 1248 1252 <span type="species:ncbi:10090">mice</span>
To determine whether infection of Iba-1 positive cells was biased to microglia or infiltrating monocytes, both cell populations were purified from spinal cords of infected mice by fluorescence activated cell sorting. Measurement of viral mRNA encoding the nucleocapsid protein revealed that microglia derived from RL-/- mice harbored 3.0-fold higher levels of viral RNA at day 7 p.i., while the relative levels in monocytes was only increased 1.6-fold relative to infected wt mice (Table 2). However, viral mRNA levels decreased in both cell types reaching comparable levels by day 10 p.i. While RNA levels for TNF were elevated in RNase L deficient microglia and monocytes by 2-fold and 1.4 fold, respectively, iNOS levels remained similar relative to wt derived cells (data not shown). IFNgamma relative to GAPDH mRNA levels in spinal cord were also modestly increased from 4.6+/-0.5 in wt mice to 8.1+/-0.3 in RL-/- mice at the peak (day 7 p.i.) and declined to 1.4+/-0.4 and 1.2+/-0.1, respectively, by day 10 p.i., confirming a modest contribution of proinflammatory cytokines to pathogenesis. Moderately increased viral RNA levels in microglia are thus consistent with foci of microglia infection in spinal cord grey matter not present in wt mice.
###end p 49
###begin title 50
Levels of viral nucleocapsid protein encoding mRNA in cell populations purified from spinal cords.
###end title 50
###begin p 51
relative to GAPDH.
###end p 51
###begin p 52
SD from two sorting experiments with pooled samples from n = 8 per group and time point.
###end p 52
###begin p 53
###xml 650 657 650 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000602-g010">Fig. 10</xref>
###xml 687 690 687 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1142 1146 1142 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Trapp1">[34]</xref>
###xml 1147 1151 1147 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Hasegawa1">[36]</xref>
###xml 1201 1205 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Alirezaei1">[37]</xref>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
Overall these data demonstrate that accelerated and enhanced demyelination in the absence of RNase L coincided with significant neuronal damage in the absence of expanded neuronal infection. Furthermore, the limited extent of increased focal glial infection appeared insufficient to mediate the pathological effect. To assess potential differences in the overall activation state of microglia, the distribution and morphology of Iba-1 positive cells was assessed in spinal cord grey matter. Microglia in wt mice were activated as demonstrated by their intense staining and ramified phenotype and localized in close proximity to neuronal cell bodies (Fig. 10). By contrast, in infected RL-/- mice, fewer microglia were activated based on their Iba-1 staining and morphology and did not show preferential association with neurons. Whether the absence of RNase L itself or infection of microglia mitigates a neuroprotective function of microglia remains to be explored. The notion that inflammatory insults disrupt neuroprotective functions by microglia is based on microglia mediated neuroprotection in models of injury and LPS preconditioning [34]-[36] and loss of protection following viral infection [37].
###end p 53
###begin title 54
RNase L enhances microglia activation.
###end title 54
###begin p 55
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Microglia activation in spinal cords from infected wt and RL-/- mice at day 7 p.i. Microglia/monocytes detected by immunoperoxidase staining using anti Iba-1antibody.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 165 172 158 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 345 348 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Silverman1">[3]</xref>
###xml 349 352 342 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Garcia1">[5]</xref>
###xml 452 460 445 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 462 469 455 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 521 524 514 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Zhou1">[8]</xref>
###xml 525 528 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-FlodstromTullberg1">[9]</xref>
###xml 529 533 522 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 679 683 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 864 868 850 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 542 545 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
###xml 1006 1009 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
IFN-alpha/beta dependent innate immunity is essential to contain viral spread during most viral infections prior to control by adaptive responses. Nevertheless, the in vivo anti-viral effector mechanisms contributing to innate viral control remain poorly understood. The best characterized pathways are mediated by activation of PKR and RNase L [3]-[5]. However, in contrast to the conclusive effects of PKR and RNase L deficiency on viral replication in vitro, in vivo studies demonstrate more subtle anti-viral effects [8],[9],[11]. During WNV infection, RNase L deficiency is manifested in profoundly altered morbidity, despite similar viral control after footpad inoculation [11]. IFN-alpha/beta-mediated anti-viral responses are also critical for controlling spread of neurotropic coronavirus within glial cell populations and preventing infection of neurons [12]. Based on its activation by numerous RNA viruses, RNase L was investigated as a prototypical anti-viral effector molecule in controlling MHV-JHM virus replication in the CNS.
###end p 57
###begin p 58
###xml 125 128 125 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Ireland1">[12]</xref>
###xml 324 327 324 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 345 348 345 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 506 509 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 688 691 688 691 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 721 724 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
RNase L deficiency was not sufficient to duplicate uncontrolled replication and the rapid uniform lethality observed in IFNAR-/- mice [12]. Nevertheless, a critical contribution to virus susceptibility was demonstrated by a significant increase in both clinical disease and mortality. Mortality was delayed by 3-4 days in RL-/- relative to IFNAR-/- mice, but could not be attributed to uncontrolled viral replication or spread to neurons. In fact, overall virus replication in brains and spinal cords of RL-/- mice was only modestly increased and declined with kinetics similar to wt mice. These latter findings were reminiscent of transiently increased viral replication in the CNS of RL-/- mice following intracerebral WNV inoculation [11].
###end p 58
###begin p 59
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-FloydSmith1">[38]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Wreschner1">[39]</xref>
###xml 254 257 247 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Malathi1">[7]</xref>
###xml 358 361 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 367 370 357 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Malathi1">[7]</xref>
###xml 654 661 637 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 694 702 677 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 748 752 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Stohlman1">[26]</xref>
###xml 1094 1102 1070 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1102 1106 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-RothCross1">[17]</xref>
###xml 1201 1208 1177 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 342 346 <span type="species:ncbi:12104?1.0">EMCV</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 372 375 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 566 569 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 733 736 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 844 847 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 1086 1089 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 1153 1156 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
In addition to direct anti-viral activities, activated RNase L degrades viral and host RNA [38],[39]. The cleavage products may in turn activate RIG-I/Mda-5 cytoplasmic pattern recognition receptors, propagating the expression of IFN-alpha/beta and ISGs [7]. While this function of RNase L is indeed evident by reduced IFN-beta production in EMCV infected RL-/- mice [7], MHV-JHM infection of the CNS presented no evidence for this pathway. The negligible affects of RNase L deficiency on overall viral replication and IFN-alpha/beta mediated responses suggest that MHV-JHM infection in the CNS does not, or only sparsely, activates OAS/RNase L activity in vivo. This finding is reminiscent of in vitro studies with the heterologous MHV-A59 strain [26]. Nevertheless, the preferential susceptibility of RNase L deficient microglia/monocytes to MHV-JHM infection demonstrates that viral RNA does activate cellular RNA sensors, albeit in a cell type specific manner. This is supported by Mda-5 triggered activation of the IFN-alpha/beta pathway in microglia and macrophages infected with MHV-A59 in vitro[17]. Whether the apparent inability of gliotropic MHV-JHM to activate RNase L in other cell types in vivo resides in distinct basal OAS/RNase L expression levels, activation of distinct OAS enzymes, or other RNA sensing receptors such as Mda-5 has not been elucidated.
###end p 59
###begin p 60
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bisbal2">[25]</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Liang1">[40]</xref>
###xml 446 449 439 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Zhou1">[8]</xref>
###xml 505 509 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Silverman3">[22]</xref>
###xml 717 720 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 145 148 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
Numerous functions of RNase L, not directly associated with anti-viral activity, may contribute to the increased susceptibility of RL-/- mice to MHV-JHM infection. RNase L plays a role in translational inhibition, regulation of mRNA stability, apoptosis, proliferation and tumor suppression [25],[40]. For example, RNase L contributes to IFN-alpha/beta mediated apoptosis, as well as homeostasis of thymocytes and splenocytes in young naive mice [8]. RNase L deficiency also delays tissue graft rejection [22] implicating a defect in T cell function or trafficking. Nevertheless, both histochemical and flow cytometric analysis revealed a similar extent and composition of inflammatory cells in the CNS of infected RL-/- and wt mice. The lack of RNase L mediated alterations in T cells was supported by similar peripheral expansion of virus-specific CD8 T cells and kinetics of viral control. Increased morbidity could thus not readily be attributed to altered inflammation or pro-inflammatory signals at the tissue level.
###end p 60
###begin p 61
###xml 140 143 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 387 391 377 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Carr1">[41]</xref>
###xml 515 518 505 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 726 730 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Savarin1">[42]</xref>
###xml 740 743 730 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 829 832 819 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1410 1413 1400 1403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1497 1500 1487 1490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1708 1711 1698 1701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1823 1826 1813 1816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 33 36 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 319 324 <span type="species:ncbi:10298?0.9377676277476449">HSV-1</span>
###xml 496 499 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 519 523 <span type="species:ncbi:10090">mice</span>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 815 818 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 833 837 <span type="species:ncbi:10090">mice</span>
###xml 1424 1428 <span type="species:ncbi:10090">mice</span>
###xml 1501 1505 <span type="species:ncbi:10090">mice</span>
###xml 1589 1593 <span type="species:ncbi:10090">mice</span>
###xml 1620 1624 <span type="species:ncbi:10090">mice</span>
###xml 1721 1725 <span type="species:ncbi:10090">mice</span>
Neuronal infection by gliotropic MHV-JHM is sparse and only evident early p.i. in wt mice. No evidence for enhanced neuronal infection in RL-/- mice thus suggested that the IFN-alpha/beta mediated anti-viral mechanisms in neurons are RNase L independent. This contrasts with a protective role for RNase L in inhibiting HSV-1 replication in neurons of IFN-beta treated trigeminal ganglia [41], and supports virus specific susceptibilities to innate anti-viral immunity. Distinguishing features in MHV-JHM infected RL-/- mice are the sustained areas of microglia infection in brain stem and focal areas of infected microglia within the spinal cord grey matter. Infected cells in spinal cord grey matter are also evident in SCID [42] and IFNAR-/- mice (unpublished observation) following infection with the gliotropic MHV-JHM. In RL-/- mice the prominent infected cells in brain stem and spinal cord grey matter were identified as Iba-1 positive microglia or infiltrating monocytes, which cannot readily be distinguished by immunohistochemistry. Nevertheless the morphology of infected cells in the grey matter was consistent with activated microglia, rather than the monocyte/macrophages with dense cytoplasm found prominently in demyelinating lesions. Furthermore, preferential microglia infection was supported by a relatively greater increase of viral RNA in microglia relative to monocytes, when comparing RL-/- versus wt mice. The prominent location of Iba-1 positive cells in grey matter of RL-/- mice could not be attributed to the absence of activated microglia in grey matter of wt mice. In fact, microglia in wt mice exhibited a more ramified phenotype surrounding neurons compared to microglia in RL-/- infected mice. It remains unclear whether abrogation of the proximal localization of microglia to neurons in RL-/- spinal cords reflects an unknown function of an RNase L enhanced neuroprotective effect, or altered function due to infection.
###end p 61
###begin p 62
###xml 258 261 258 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Schwartz1">[28]</xref>
###xml 207 210 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 277 281 <span type="species:ncbi:10090">mice</span>
###xml 653 656 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
Surprisingly, both prolonged brain stem infection and enhanced spinal cord grey matter infection was associated with more severe demyelination and axonal damage. Overall, the CNS pathology characteristic of MHV-JHM infection was accelerated by 3-4 days in RL-/- relative to wt mice. Although infection of microglia correlated with a subsequent increase in apoptotic cells, apoptotic cells surrounding neurons were only evident in spinal cord, not in brain stem. The inability to detect increased numbers of infected or apoptotic cells in spinal cord white matter is consistent with both an apparent lack of RNase L activation in oligodendrocytes during MHV-JHM infection and paucity of apoptotic oligodendrocytes in wt mice [28].
###end p 62
###begin p 63
###xml 334 337 334 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 628 632 628 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-DasSarma1">[33]</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Trapp1">[34]</xref>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Hasegawa1">[36]</xref>
###xml 1528 1532 1524 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Howe1">[30]</xref>
###xml 1731 1735 1727 1731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Alirezaei1">[37]</xref>
###xml 1941 1945 1937 1941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Streit1">[43]</xref>
###xml 1946 1950 1942 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Minagar1">[47]</xref>
###xml 2099 2103 2095 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Samuel1">[11]</xref>
###xml 2262 2269 2258 2265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 615 618 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 1708 1711 <span type="species:ncbi:11723?0.9432672590567327|species:ncbi:12845?0.02460697197539303">SIV</span>
###xml 2085 2088 <span type="species:ncbi:11082?0.9877551020408163">WNV</span>
Whether apoptotic cells originated from infected myeloid cells themselves or from lymphocytes migrating to the infected areas and exerting effector function is unclear. Preliminary analysis showed no co-localization of activated caspase 3 and Iba-1 (data not shown). Overall, the neurologic disability and morbidity of the infected RL-/- mice appears to result from axonal or neural degeneration, independent of neuronal infection in both brain stem and spinal cord. The enhanced demyelination phenotype is thus distinct from demyelination attributed to enhanced white matter infection by recombinant neuronotropic MHV variants [33]. RNase L deficiency and infection of microglia may contribute to this pathology in several ways. Infection in the absence of RNase L may impair neuroprotective effects exerted by microglia under inflammatory conditions [34]-[36]. Alternatively, enhanced infection of microglia may increase proinflammatory responses resulting not only in enhanced recruitment of T cells and monocytes, but also increased local production of neurotoxic factors such as TNF, nitric oxide, oxidative radicals, and matrix metalloproteases. However, only modest increases in IFNgamma mRNA in spinal cord, as well as minor differences in TNF and iNOS mRNA in microglia/monocytes suggest these effects may only be apparent at a focal level. Increased localized T cell effector function, manifested in release of perforin and granzymes, has also been shown to contribute to axonal injury without affecting demyelination [30]. Lastly, RNase L deficient and/or infected microglia may perturb normal microglia functions in maintaining neuronal health as indicated by disruption of neuronal autophagy by SIV infected microglia [37]. It thus remains to be determined to what extent accelerated and more severe pathology is due to disruption of the neuroprotective functions of microglia and/or from overt activation due to infected cells [43]-[47]. Independent of a pathogenic effect, it is interesting to note that the absence of RNase L also enhanced macrophage susceptibility to WNV infection [11]. Whether this reflects differential activation of OAS enzymes or participation of other pattern recognition receptors such as Mda-5 in susceptible cell types in vivo remains to be elucidated.
###end p 63
###begin p 64
In summary, these data highlight a novel role of RNase L in protection from virus induced demyelination. Although RNase L did not play an overt anti-viral role as measured by viral replication, it did provide specific protection from focal infection of microglia/macrophages in the CNS. RNase L was not crucial in protecting neurons from infection and played no obvious role in protecting oligodendrocytes or astrocytes. Furthermore, RNase L deficiency did not alter proinflammatory responses, diminish IFN-alpha/beta mediated signals, or dampen adaptive immune mediators. The results rather uncover how subtle local alterations in viral tropism may affect the balance between neuroprotection and neurotoxicity mediated by microglia/macrophages.
###end p 64
###begin title 65
Materials and Methods
###end title 65
###begin title 66
Animals, viruses, and clinical scores
###end title 66
###begin p 67
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 450 454 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Fleming1">[48]</xref>
###xml 596 600 592 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Fleming1">[48]</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">Mice</span>
###xml 427 430 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
C57BL/6 mice were purchased from the National Cancer Institute (NCI, Fredrick, MD). C57BL/6-RL-/- mice were bred and housed under pathogen-free conditions in the Biological Resources Unit of the Cleveland Clinic. All procedures were performed in compliance with protocols approved by the Institutional Animal Care and Use Committee. Mice were infected at 6 weeks of age by intracranial injection with 250 PFU of the gliotropic MHV-JHM variant V2.2-1 [48] in 30 microL endotoxin-free Dulbecco's phosphate buffered saline (DPBS). The severity of clinical disease was graded as previously described [48]: 1 = ruffled fur, 2 = slow righting reflex, 3 = loss of righting reflex, 4 = moribund. Following intraperitoneal administration of ketamin/xylaxine (100 mg/kg/10 mg/kg), mice were perfused intracardially with 10 mL DPBS. Brains, spinal cords, spleens, cervical lymph nodes (CLN) and livers were collected and processed as described below.
###end p 67
###begin title 68
Virus titer and cell isolation
###end title 68
###begin p 69
###xml 421 425 415 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Fleming1">[48]</xref>
###xml 705 709 699 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bergmann2">[23]</xref>
###xml 80 85 <span type="species:ncbi:10090">mouse</span>
Brains were bisected sagittally. One half-brain and whole spinal cord from each mouse were homogenized in ice cold Tenbroeck glass grinders in 4 mL or 2 mL of DPBS, respectively. Homogenates were clarified by centrifugation for 7 min at 400xg. Supernatants were stored at -80degreesC. Virus in supernatants was measured by plaque assay on monolayers of delayed brain tumor (DBT) astrocytoma cells as previously described [48]. CNS cells from homogenate pellets were resuspended in RPMI containing 25 mM HEPES, adjusted to 30% Percoll (Pharmacia, Upsalla, Sweden), underlayed with 1 mL 70% Percoll, centrifuged at 800xg for 30 minutes and collected from the 30%/70% Percoll interface as previous described [23]. Purified CNS cells were washed and resuspended in RPMI.
###end p 69
###begin title 70
Flow cytometry and Fluorescence Activated Cell Sorting
###end title 70
###begin p 71
###xml 714 715 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 767 771 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bergmann2">[23]</xref>
###xml 154 159 <span type="species:ncbi:10090">mouse</span>
###xml 173 176 <span type="species:ncbi:10116">rat</span>
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
###xml 286 292 <span type="species:ncbi:9913">bovine</span>
###xml 527 532 <span type="species:ncbi:10090">mouse</span>
Cell populations isolated from the brain and spinal cord were phenotyped using four-color flow cytometry. Prior to staining, cells were incubated with 1% mouse serum and 1% rat anti-mouse FcgammaIII/IIR monoclonal antibody (mAb) in fluorescent antibody cell sorting (FACS) buffer (0.5% bovine serum albumin in DPBS) for 20 minutes at 4degreesC to block non-specific binding. Cell types were identified using fluorescein isothiocyanate-, phycoerythrin-, peridinin-chlorophyll-protein complex- or allophycocyanin-conjugated anti-mouse mAb: Ly-6 g (1A8), CD4 (GK1.5), CD8 (53.67) (all from BD Biosciences, San Diego, CA) and F4/80 (CI:A3-1; Serotec, Raleigh, NC). Virus specific CD8 T cells were identified using H-2Db/S510 MHC class I tetramers as described previously [23]. Cells were incubated with antibodies for 30 minutes on ice, washed twice with FACS buffer and fixed with 2% paraformaldehyde for 10 minutes on ice. At least 100,000 events were acquired on a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA) for subsequent data analysis using Flow-Jo 7 Software (Tree Star, Inc. Ashland, OR).
###end p 71
###begin p 72
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Gonzalez1">[27]</xref>
###xml 219 223 219 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Malone1">[49]</xref>
###xml 981 983 975 977 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 988 989 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 994 995 988 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1004 1006 998 1000 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 1012 1013 1006 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1018 1019 1012 1013 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:9913">calf</span>
###xml 566 571 <span type="species:ncbi:10090">mouse</span>
For fluorescence activated cell sorting of microglia and monocyte populations, spinal cords from eight mice per group were finely minced using a razor blade and dissociated in a 0.25% trypsin solution as described [27],[49] at 37degreesC for 30 minutes with periodic tituration. Trypsin was quenched by addition of RPMI supplemented with 25 mM HEPES and 20% new born calf serum. The dissociated cells were washed in RPMI containing 25 mM HEPES, 1% FCS, then isolated from the interphase of a 30%/70% percoll gradient as described above. Cells were incubated with 1% mouse serum and CD16/32 prior to staining with allophycocyanin-conjugated mAb specific for CD45 (30-F11), peridinin-chlorophyll protein-conjugated CD11b (M1/70) (BD Biosciences, San Diego, CA) and phycoerythrin-conjugated mAb specific for F4/80 (CI:A3-1; Serotec, Raleigh, NC). Monocyte/macrophages and microglia were purified on a FACSAria cell sorter (BD Biosciences, San Diego, CA) based on their respective CD45hiCD11b+F4/80+ and CD45lo CD11b+F4/80+ phenotypes.
###end p 72
###begin title 73
Histopathological analysis and fluorescence immunocytochemistry
###end title 73
###begin p 74
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bergmann3">[50]</xref>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Bergmann3">[50]</xref>
###xml 1384 1388 1384 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000602-Gonzalez1">[27]</xref>
###xml 433 438 <span type="species:ncbi:9796">horse</span>
###xml 444 449 <span type="species:ncbi:10090">mouse</span>
###xml 497 502 <span type="species:ncbi:9796">horse</span>
###xml 503 509 <span type="species:ncbi:3726">radish</span>
###xml 643 648 <span type="species:ncbi:10090">mouse</span>
###xml 941 947 <span type="species:ncbi:9986">rabbit</span>
One half-brain and whole spinal cords were fixed with formalin and embedded in paraffin. Sections were stained with either hematoxylin and eosin or luxol fast blue as described [50]. Distribution of viral antigen was determined by immunoperoxidase staining (Vectastain-ABC kit; Vector Laboratory, Burlingame, CA) using mAb J.3.3, specific for the carboxyl terminus of the viral nucleocapsid protein as primary antibody, biotinylated horse anti-mouse as secondary antibody, streptavidin-conjugated horse radish peroxidise and 3,3'-diaminobenzidine substrate (Vector Laboratory) [50]. Similarly, immunoperoxidase staining for neurofilament used mouse anti-phosphorylated and anti-non-phosphorylated neurofilament mAb (SMI-31 and SMI-32, Covance, Princeton, NJ) and immunoperoxidase staining for microglia/macrophages used anti-ionized calcium-binding adapter molecule-1 antibody (Iba-1, Abcam, Cambridge, MA). Apoptotic cells were detected by rabbit anti-activated caspase-3 Ab (Asp175, Cell Signalling Technology, Beverly, MA). Sections were scored for inflammation, viral antigen, apoptotic cells, axonal damage and demyelination in a blinded fashion. Representative fields-of-view were identified based on average scores of all sections in each experimental group. For calculation of the percentage area of demyelination, sections were digitized and analysed as previously described [27].
###end p 74
###begin p 75
###xml 414 420 <span type="species:ncbi:9913">bovine</span>
###xml 446 450 <span type="species:ncbi:9925">goat</span>
###xml 500 503 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 518 524 <span type="species:ncbi:9986">rabbit</span>
###xml 604 610 <span type="species:ncbi:9986">rabbit</span>
###xml 716 720 <span type="species:ncbi:9925">goat</span>
###xml 726 731 <span type="species:ncbi:10090">mouse</span>
###xml 752 756 <span type="species:ncbi:9925">goat</span>
###xml 762 768 <span type="species:ncbi:9986">rabbit</span>
To identify infected cell types, spinal cords were embedded in TissueTek O.C.T. compound (Andwin Scientific, Tryon, NC), flash frozen in liquid nitrogen and stored at -80degreesC. Blocks were warmed to -20degreesC prior to cutting 10 microm sections by cryostat at this temperature. Following fixation with 4% paraformaldehyde for 30 minutes at room temperature, non-specific antibody binding was blocked using 1% bovine serum albumin, 5% normal goat serum. Infected cells were identified using anti-MHV-JHM J3.3 mAb, rabbit anti-glial fibrillary acidic protein antibody (GFAP, Abcam, Cambridge, MA) and rabbit anti-ionized calcium-binding adapter molecule-1 antibody (Iba-1, Wako, Richmond, VA) in combination with goat anti-mouse Alexa-fluor 488 and goat anti-rabbit Alexa-fluor 594-conjugated IgG (Invitrogen, Carlsbad, CA) as secondary antibodies, respectively. Sections were mounted with ProLong Gold antifade mounting media containing 4',6-diamidino-2-phenylindole (Invitrogen, Carlsbad, CA). Imaging of immunofluorescent sections was performed with a Leica SP-5 confocal microscope (Leica Microsystems, Bannockburn, IL). Z-projections of sections were processed by ImageJ software (National Institutes of Health, Bethesda, MD)
###end p 75
###begin title 76
Real-time PCR
###end title 76
###begin p 77
One-half brains and whole spinal cords were snap frozen in liquid nitrogen and stored at -80degreesC. Frozen brain or spinal cord tissue was homogenized in 2 mL and 1 mL Trizol reagent (Invitrogen, Carlsbad, CA), respectively, in RNase-free Tenbroeck glass grinders. RNA was purified according to the manufacturer's protocol (Invitrogen, Carlsbad, CA). Briefly, 0.2 mL chloroform/1 mL trizol (Sigma-Aldrich, St. Louis, MO) was added to homogenate, mixed and centrifuged at 12,000xg for 15 minutes at 4degreesC. RNA was precipitated from the aqueous phase by addition of isopropyl alcohol and centrifugation at 12,000xg for 10 min at 4degreesC washed in RNase-free 75% ethanol and resuspended in Ultrapure DNase/RNase-free water (Invitrogen, Carlsbad, CA). Cells isolated by FACS were immediately resuspended in 400 microL of Trizol reagent (Invitrogen, Carlsbad, CA) and treated as above. Isolated total RNA was treated with DNase1, using the DNA-free kit (Applied Biosystems, Foster City, CA) following the manufacturer's protocol. The concentration and purity of RNA was measured by spectrophotometry at 260/280 nm. RNA integrity was confirmed by 1.2% formaldehyde-agarose gel electrophoresis.
###end p 77
###begin p 78
###xml 495 523 485 513 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTTACAGCAACCATGGGAGA-3&#8242;</named-content>
###xml 528 552 518 542 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCAGCTTCCATGTGAAGTGAC-3&#8242;</named-content>
###xml 574 600 564 590 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGAGGAAGAGGTTGCCTGGA-3&#8242;</named-content>
###xml 605 633 595 623 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTCGTTGTACTCATGACTGCTG-3&#8242;</named-content>
###xml 644 676 634 666 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AAAAATGTCTGCTTCTTGAATTCTGA-3&#8242;</named-content>
###xml 681 706 671 696 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGTGCCTTTGGCAGTGGAT-3&#8242;</named-content>
###xml 719 743 709 733 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TAAGAGTGATTGGCGTCG-3&#8242;</named-content>
###xml 748 774 738 764 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATTGGGTTGAGTAGTTGCAG-3&#8242;</named-content>
###xml 785 810 775 800 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CCTGGTACGGGCATTGCT-3&#8242;</named-content>
###xml 815 839 805 829 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CATGCGGCCTCCTTTGAG-3&#8242;</named-content>
###xml 855 882 841 868 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCCACCACGCTCTTCTGTCT-3&#8242;</named-content>
###xml 887 916 873 902 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGTCTGGGCCATAGAACTGATG-3&#8242;</named-content>
###xml 955 982 941 968 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; -CATGGCCTTCCGTGTTCCTA-3&#8242;</named-content>
###xml 987 1014 973 1000 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ATGCCTGCTTCACCACCTTCT-3&#8242;</named-content>
###xml 1753 1775 1704 1726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(CT(GAPDH)-CT(TARGET))</sup>
Reverse transcription was performed on 2 microg total RNA isolated from brain and spinal cord or all total RNA isolated from FACS sorted cells, primed with 250 ng random hexamers, (Invitrogen, Carlsbad, CA) using MMLV reverse transcriptase (Invitrogen, Carlsbad, CA) for 50 minutes at 37degreesC. Real-time PCR was performed using SYBR Green 2xMaster Mix (Applied Biosystems, Foster City, CA) for the following primer sets: Interferon-induced protein with tetratricopeptide repeats (IFIT)-1: F: 5'-CCTTTACAGCAACCATGGGAGA-3', R: GCAGCTTCCATGTGAAGTGAC-3'; IFIT-2 (ISG-54): F: 5'-AGAGGAAGAGGTTGCCTGGA-3', R: 5'-CTCGTTGTACTCATGACTGCTG-3'; OAS2: F: 5'-AAAAATGTCTGCTTCTTGAATTCTGA-3', R: 5'-TGTGCCTTTGGCAGTGGAT-3'; JHMV-N: F: 5'-TAAGAGTGATTGGCGTCG-3', R: 5'-ATTGGGTTGAGTAGTTGCAG-3'; iNOS: F: 5'- CCTGGTACGGGCATTGCT-3', R: 5'-CATGCGGCCTCCTTTGAG-3'; TNF-alpha: F: 5'- GCCACCACGCTCTTCTGTCT-3', R: 5'- GGTCTGGGCCATAGAACTGATG-3' and for endogenous control, GAPDH: F: 5' -CATGGCCTTCCGTGTTCCTA-3', R: 5'-ATGCCTGCTTCACCACCTTCT-3'. The reaction conditions were: 95degreesC for 10 minutes, followed by 40 cycles of: denaturation at 95degreesC for 10 seconds, elongation at 60degreesC for 30 seconds and annealing at 72degreesC for 30 seconds. IFN-beta1, IFN-alpha4 and IFN-gamma levels were determined by real time PCR using ABI Gene Expression Assays with 2xUniversal Taqman Fast Master Mix (Applied Biosystems, Foster City, CA), using manufacturer default cycling conditions and GAPDH expression as an endogenous control. All real-time reactions were run using an ABI 7500fast real-time cycler and analysed with 7500fast software (Applied Biosystems, Foster City, CA). Data presented are expressed as fold-induction relative to GAPDH based on the following formula: (2(CT(GAPDH)-CT(TARGET)))*1000.
###end p 78
###begin title 79
Statistical analysis
###end title 79
###begin p 80
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
Students' t-Test with equal variance was used to compare RL-/- and wt C57BL/6 mice. Significant differences between groups are noted by: *,  = P</=0.05.
###end p 80
###begin p 81
The authors thank Dr. Bruce Trapp for helpful discussions and comments on the manuscript. We also thank Wen Wei and Ernesto Barron for excellent assistance with the histopathology and Jennifer Powers for cell purification by FACS.
###end p 81
###begin title 82
References
###end title 82
###begin article-title 83
Interferons at age 50: past, current and future impact on biomedicine.
###end article-title 83
###begin article-title 84
Type 1 interferons and the virus-host relationship: a lesson in detente.
###end article-title 84
###begin article-title 85
A scientific journey through the 2-5A/RNase L system.
###end article-title 85
###begin article-title 86
Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response.
###end article-title 86
###begin article-title 87
The dsRNA protein kinase PKR: virus and cell control.
###end article-title 87
###begin article-title 88
Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
###end article-title 88
###begin article-title 89
Small self-RNA generated by RNase L amplifies antiviral innate immunity.
###end article-title 89
###begin article-title 90
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.
###end article-title 90
###begin article-title 91
RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection.
###end article-title 91
###begin article-title 92
###xml 50 65 <span type="species:ncbi:11082">West Nile virus</span>
RNase L plays a role in the antiviral response to West Nile virus.
###end article-title 92
###begin article-title 93
PKR and RNase L contribute to protection against lethal West Nile Virus infection by controlling early viral spread in the periphery and replication in neurons.
###end article-title 93
###begin article-title 94
Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.
###end article-title 94
###begin article-title 95
Interferon and cytokine responses to SARS-coronavirus infection.
###end article-title 95
###begin article-title 96
Control of coronavirus infection through plasmacytoid dendritic cell-derived type I interferon.
###end article-title 96
###begin article-title 97
###xml 85 103 <span type="species:ncbi:11138">murine coronavirus</span>
Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection.
###end article-title 97
###begin article-title 98
Viral induction of central nervous system innate immune responses.
###end article-title 98
###begin article-title 99
###xml 0 18 <span type="species:ncbi:11138">Murine coronavirus</span>
###xml 19 40 <span type="species:ncbi:11138">mouse hepatitis virus</span>
Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia.
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist.
###end article-title 100
###begin article-title 101
###xml 41 72 <span type="species:ncbi:11140">murine hepatitis virus strain 3</span>
###xml 74 77 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 122 125 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
###end article-title 101
###begin article-title 102
Coronavirus infection of the central nervous system: host-virus stand-off.
###end article-title 102
###begin article-title 103
###xml 0 18 <span type="species:ncbi:11138">Murine coronavirus</span>
Murine coronavirus infection: a paradigm for virus-induced demyelinating disease.
###end article-title 103
###begin article-title 104
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Skin allograft rejection is suppressed in mice lacking the antiviral enzyme, 2',5'-oligoadenylate-dependent RNase L.
###end article-title 104
###begin article-title 105
Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.
###end article-title 105
###begin article-title 106
###xml 43 65 <span type="species:ncbi:11138">murine hepatitis virus</span>
###xml 78 81 <span type="species:ncbi:11138?0.8024691358024691">MHV</span>
Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination.
###end article-title 106
###begin article-title 107
Diverse functions of RNase L and implications in pathology.
###end article-title 107
###begin article-title 108
CTL effector function within the central nervous system requires CD4+ T cells.
###end article-title 108
###begin article-title 109
Inhibition of interferon-gamma signaling in oligodendroglia delays coronavirus clearance without altering demyelination.
###end article-title 109
###begin article-title 110
###xml 87 108 <span type="species:ncbi:11138">mouse hepatitis virus</span>
Differential induction of apoptosis in demyelinating and nondemyelinating infection by mouse hepatitis virus.
###end article-title 110
###begin article-title 111
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: When can axonal injury be beneficial?
###end article-title 111
###begin article-title 112
Absence of perforin expression confers axonal protection despite demyelination.
###end article-title 112
###begin article-title 113
###xml 114 118 <span type="species:ncbi:10090">mice</span>
Role of IFN-gamma responsiveness in CD8 T-cell-mediated viral clearance and demyelination in coronavirus-infected mice.
###end article-title 113
###begin article-title 114
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus.
###end article-title 114
###begin article-title 115
###xml 46 67 <span type="species:ncbi:11138">mouse hepatitis virus</span>
Demyelinating and nondemyelinating strains of mouse hepatitis virus differ in their neural cell tropism.
###end article-title 115
###begin article-title 116
Evidence for synaptic stripping by cortical microglia.
###end article-title 116
###begin article-title 117
Microglia overexpressing the macrophage colony-stimulating factor receptor are neuroprotective in a microglial-hippocampal organotypic coculture system.
###end article-title 117
###begin article-title 118
Enhanced cell-to-cell contacts between activated microglia and pyramidal cell dendrites following kainic acid-induced neurotoxicity in the hippocampus.
###end article-title 118
###begin article-title 119
Disruption of neuronal autophagy by infected microglia results in neurodegeneration.
###end article-title 119
###begin article-title 120
Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate-dependent endonuclease.
###end article-title 120
###begin article-title 121
Interferon action-sequence specificity of the ppp(A2'p)nA-dependent ribonuclease.
###end article-title 121
###begin article-title 122
RNase L: its biological roles and regulation.
###end article-title 122
###begin article-title 123
###xml 27 54 <span type="species:ncbi:10298">herpes simplex virus type 1</span>
Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway.
###end article-title 123
###begin article-title 124
Memory CD4+ T-cell-mediated protection from lethal coronavirus encephalomyelitis.
###end article-title 124
###begin article-title 125
Microglia as neuroprotective, immunocompetent cells of the CNS.
###end article-title 125
###begin article-title 126
Molecular and cellular immune mediators of neuroprotection.
###end article-title 126
###begin article-title 127
Multiple sclerosis: novel perspectives on newly forming lesions.
###end article-title 127
###begin article-title 128
Experimental models of neuroprotection relevant to multiple sclerosis.
###end article-title 128
###begin article-title 129
###xml 99 102 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis.
###end article-title 129
###begin article-title 130
###xml 39 57 <span type="species:ncbi:11138">murine coronavirus</span>
Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies.
###end article-title 130
###begin article-title 131
Induction of class I antigen processing components in oligodendroglia and microglia during viral encephalomyelitis.
###end article-title 131
###begin article-title 132
Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
###end article-title 132
###begin p 133
The authors have declared that no competing interests exist.
###end p 133
###begin p 134
This work was supported by National Institutes of Health grants NS18146 (to SAS), AI47249 (to CCB) and CA044059 (to RS). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.
###end p 134

